SCHEMBL21925688

SCHEMBL21925688

BC(B)(Nc1cccc2c1C(B)(O)N(C1(O)CCC(=O)NC1=O)C2=O)c1ccc(C(B)(O)N2C(O)(O)C(O)(O)OC(O)(O)C2(O)O)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23939074 0.77 — —
SCHEMBL23938950 0.76 — —
SCHEMBL19310286 0.75 — —
SCHEMBL19310114 0.72 — —
SCHEMBL21281531 0.72 — —
SCHEMBL21927112 0.71 — —
SCHEMBL21281376 0.69 CRBN (0.35) —
SCHEMBL21925699 0.67 — —
SCHEMBL23938987 0.67 — —
SCHEMBL21281396 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2020-04-29 — — EP disclosed
Send feedback